We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$64.8B
1-Year Est. Return
42.7%
This Fund
S&P 500
This Quarter
Est. Return
+27.07%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+829.83%
AUM
$39.1B
AUM Growth
+$5.57B
(+17%)
Cap. Flow
-$1.33B
Cap. Flow
% of AUM
-3.4%
Top 10 Holdings %
Top 10 Hldgs %
25.2%
Holding
834
New
111
Increased
262
Reduced
309
Closed
110
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Royalty Pharma
RPRX
|
+$2.28B |
| 2 |
Otis Worldwide
OTIS
|
+$193M |
| 3 |
Burlington
BURL
|
+$191M |
| 4 |
AbbVie
ABBV
|
+$178M |
| 5 |
Wayfair
W
|
+$144M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$1.66B |
| 2 |
Lockheed Martin
LMT
|
+$339M |
| 3 |
Johnson & Johnson
JNJ
|
+$262M |
| 4 |
Pfizer
PFE
|
+$167M |
| 5 |
Target
TGT
|
+$141M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.52% |
| 2 | Healthcare | 19.78% |
| 3 | Consumer Discretionary | 13.09% |
| 4 | Financials | 11.33% |
| 5 | Industrials | 8.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ADN
401
DELISTED
Advent Technologies
ADN
| $18.4M | 0.05% |
60,000
| – | – |
|
402
Delta Air Lines
DAL
$61.3B
| $18.4M | 0.05% |
655,811
-20,872
| -3% | -$531K |
|
403
Take-Two Interactive
TTWO
$43.9B
| $18.4M | 0.05% |
131,634
-226,033
| -63% | -$29.6M |
|
404
Fortinet
FTNT
$120B
| $18.2M | 0.05% |
664,090
-152,000
| -19% | -$3.82M |
|
405
Lamar Advertising Co
LAMR
$16.1B
| $18.1M | 0.05% |
271,567
+175,000
| +181% | +$10.7M |
|
|
PXD
406
DELISTED
Pioneer Natural Resource Co.
PXD
| $18.1M | 0.05% |
184,823
-1,377,617
| -88% | -$121M |
|
407
uniQure
QURE
$3.07B
| $18M | 0.05% |
400,000
+35,000
| +10% | +$2.07M |
|
|
ORTX
408
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
| $18M | 0.05% |
300,000
-5,200
| -2% | -$476K |
|
409
AerCap
AER
$24.4B
| $17.9M | 0.05% |
582,542
-121,246
| -17% | -$3.47M |
|
410
Diamondback Energy
FANG
$52.4B
| $17.9M | 0.05% |
428,540
-15,600
| -4% | -$637K |
|
|
ALUS
411
DELISTED
Alussa Energy Acquisition Corp
ALUS
| $17.7M | 0.05% |
1,800,000
| – | – |
|
|
FITB
412
Fifth Third Bancorp
FITB
$52.2B
| $17.7M | 0.05% |
917,350
-324,550
| -26% | -$6.01M |
|
413
Granite Construction
GVA
$5.4B
| $17.7M | 0.05% |
923,356
-634,399
| -41% | -$10.8M |
|
414
Zurn Elkay Water Solutions
ZWS
$8.75B
| $17.5M | 0.04% |
+1,245,600
| New | +$16.3M |
|
415
Quest Diagnostics
DGX
$26B
| $17.4M | 0.04% |
153,100
+3,500
| +2% | +$371K |
|
416
CBRE Group
CBRE
$43.8B
| $17.4M | 0.04% |
384,500
+6,300
| +2% | +$272K |
|
417
Tractor Supply
TSCO
$17.5B
| $17.4M | 0.04% |
659,500
-615,500
| -48% | -$13.5M |
|
418
Caterpillar
CAT
$401B
| $17.4M | 0.04% |
137,166
+33,010
| +32% | +$3.91M |
|
419
Paycom
PAYC
$8.15B
| $17.3M | 0.04% |
55,850
+17,850
| +47% | +$4.75M |
|
420
Las Vegas Sands
LVS
$29.7B
| $17.2M | 0.04% |
378,500
-6,400
| -2% | -$301K |
|
421
Essex Property Trust
ESS
$18.5B
| $17.2M | 0.04% |
75,200
+1,100
| +1% | +$264K |
|
|
CERN
422
DELISTED
Cerner Corp
CERN
| $17.2M | 0.04% |
251,320
-46,800
| -16% | -$3.22M |
|
423
Ameriprise Financial
AMP
$49.6B
| $17.2M | 0.04% |
114,668
-2,000
| -2% | -$256K |
|
424
Cardinal Health
CAH
$56B
| $17.2M | 0.04% |
329,300
-6,000
| -2% | -$309K |
|
425
Cencora
COR
$61.7B
| $16.9M | 0.04% |
167,900
-2,900
| -2% | -$267K |
|
Similar funds
Adage Capital Partners's Q2 2020 Portfolio in Review
As of Q2 2020, Adage Capital Partners held 834 positions worth $39.1B, up 17% from $33.5B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Adage Capital Partners withdrew a net $1.33B in Q2 2020, closing 110 positions and reducing 309 holdings. Its most notable exit was Allergan plc, an estimated $1.66B position sold in full.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 19% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Adage Capital Partners opened a new position in Royalty Pharma worth $2.23B.
- Adage Capital Partners's largest Q2 2020 buy was Royalty Pharma: 46,015,330 shares worth $2.23B.
- Adage Capital Partners added most to Burlington in Q2 2020, an estimated $191M increase.
- Adage Capital Partners's biggest Q2 2020 reduction was Lockheed Martin, cutting an estimated $339M.
- Adage Capital Partners fully exited Allergan plc in Q2 2020, selling an estimated $1.66B.
- Adage Capital Partners's ten largest holdings make up 25% of its $39.1B portfolio in Q2 2020.
- Adage Capital Partners opened 111 new positions and closed 110 in Q2 2020.
- Adage Capital Partners's portfolio value rose 17% quarter-over-quarter to $39.1B.
Based on Adage Capital Partners's 13F filing for Q2 2020, filed 14 Aug 2020.